A single-centre, randomized, double-blind, crossover, single-dose clinical trial to compare bilastine, desloratadine, rupatadine and placebo in the suppression of wheal and flare induced by intradermal histamine in healthy volunteers.

Trial Profile

A single-centre, randomized, double-blind, crossover, single-dose clinical trial to compare bilastine, desloratadine, rupatadine and placebo in the suppression of wheal and flare induced by intradermal histamine in healthy volunteers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Bilastine (Primary) ; Desloratadine (Primary) ; Rupatadine (Primary)
  • Indications Allergic conjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
  • Focus Therapeutic Use
  • Sponsors FAES Farma
  • Most Recent Events

    • 10 Oct 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 26 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top